Article Text

Download PDFPDF
Case report
Concomitant myopericarditis and takotsubo syndrome following immune checkpoint inhibitor therapy
  1. Nicholas Yick Loong Tan1,
  2. Nandan S Anavekar1 and
  3. Brandon M Wiley1,2
  1. 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
  1. Correspondence to Dr Brandon M Wiley; brandowiley{at}gmail.com

Abstract

A 62-year-old man with metastatic hepatocellular carcinoma presented with ST elevation myocardial infarction had received one dose of nivolumab 3 weeks prior. Cardiac catheterisation was negative for obstructive coronary artery disease. He was transferred to the cardiac intensive care unit due to ventricular arrhythmias and markedly elevated troponin T levels. Transthoracic echocardiogram showed severely depressed left ventricular ejection fraction of 18% (normal 55%–70%) with mid and apical ballooning consistent with takotsubo syndrome (TTS). Intravenous glucocorticoids were administered due to suspicion for superimposed myocarditis. Cardiac MRI 3 days later showed mid-myocardial and subepicardial delayed enhancement in the inferior and lateral walls as well as apex indicative of myopericarditis. He clinically improved on steroids and was discharged with outpatient follow-up. This case highlights major cardiac complications that may arise with immune checkpoint inhibitor therapy. In addition, it emphasises the importance of assessing for concomitant myocarditis even when initial imaging suggests TTS.

  • heart failure
  • cardiovascular system
  • immunological products and vaccines
  • chemotherapy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors NT was responsible for compiling the case report material and writing the first draft of the manuscript. NA and BW provided critical input into the choice of images to be included in the case report. NA and BW also made important edits to the manuscript text. All authors approved of the manuscript’s final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.